Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Peptide synthesis is a process of creating short sequences of polypeptides by adding one amino acid at a time. This process is useful for creating specific sequences that represent epitopes of certain protein domains that may or may not be modified by moieties, such as phosphate groups. Peptide synthesis has become one of the most important methodologies in bio-organic chemistry for research and diagnosis. Moreover, increasing incidence of infectious diseases is expected to boost the market growth. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC) in February 2020, reports that the number of visits with infectious and parasitic diseases to physician offices as the primary diagnosis were 15.5 million in 2016 in the U.S.
The global peptide synthesis market is estimated to be valued at US$ 348.9 million in 2020 and is expected to exhibit a CAGR of 6.6% during the forecast period (2020-2027).
Figure 1. Global Peptide Synthesis Market Share (%), By Region, 2020
Inorganic strategies such as collaborations by market players for peptide synthesis is expected to propel growth of the global peptide synthesis market
Major players are focusing on expanding their business with inorganic strategies such as collaborations and this is expected to boost the market growth over the forecast period. For instance, in January 2018, Imcyse SA, a clinical-stage biotech company based in Belgium entered into a collaboration with leading multinational pharmaceutical corporation, Pfizer, Inc. The collaboration aimed at development of a certain modified peptide called Imotope. This particular peptide is synthesized for treating rheumatoid arthritis and other chronic diseases.
Moreover, increasing incidence of cancer cases is expected to boost the market growth. For instance, according to an article published by the World Health Organization in 2018, 18.1 million new cancer cases are reported every year across the globe. Among these, 300,000 cases are diagnosed among children aged 0 to 19 years.
Peptide Synthesis Market Report Coverage
||Market Size in 2020:
||US$ 348.9 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 546.3 mMn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product:
- Reagents & Consumables
- Equipment: Peptide Synthesizers, Lyophilizers, Chromatography Equipment.
- By Technology: Solid Phase, Liquid Phase, Hybrid & Recombinant.
- By Application:
- Therapeutics: Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, Others.
- By End User: Pharmaceutical and Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), Academic and Research Institutes.
GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB
- Rising incidence of acute and chronic diseases
- Product development and ongoing trials for peptide synthesis
|Restraints & Challenges:
- Lack of regulations for the peptide synthesis
Figure 2. Global Peptide Synthesis Market Share (%), By Product, 2020
Increasing cancer cases in North America is expected to boost the market growth
North America is expected to hold dominant position in the global peptide synthesis market, owing to increasing new cases of cancer in the region. For instance, according to an article published by the American Cancer Association in 2018, reports that around 1,735,350 new cancer cases were diagnosed and 609,640 cancer deaths occurred in the U.S.
Global Peptide Synthesis Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector, which has been impacted significantly by the COVID-19 pandemic.
The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.
As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the global peptide synthesis market during the forecast period.
Major players operating in the global peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others.